Stock to Keep Your Eyes on: Verona Pharma plc (NASDAQ: VRNA)
VERONA PHARMA P/S ADR (NASDAQ: VRNA) stock price moved downward at -2.21%. Its total market capitalization is $52452664. Its day
Read MoreVERONA PHARMA P/S ADR (NASDAQ: VRNA) stock price moved downward at -2.21%. Its total market capitalization is $52452664. Its day
Read MoreACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) changed 0.17% to recent value of $46.41. The stock transacted 765114 shares during most recent
Read MoreCompugen Ltd. (NASDAQ: CGEN) stock rose 2.08% and closed at 5.4. The stock opened the session at $5.18 and touched
Read MoreAmedisys, Inc. (NASDAQ: AMED) noted an up move of 0.62% in most recent trading session with finishing price of $149.25.
Read MorePfizer Inc. (NYSE: PFE) observed a decline of -1.86% on Thursday, trading period with closing price of $36.91. The company’s
Read MoreRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) observed a climb of 6.93% on TUESDAY, trading period with closing price of $332.6. The
Read MoreAptevo Therapeutics Inc. (NASDAQ: APVO) witnessed a loss of -2.37% in recent trading period with closing price of $0.63. The
Read MoreMallinckrodt plc (NYSE: MNK) settled surge of 13.91% in recent trading period with closing price of $3.85. The company’s last
Read MorePulmatrix, Inc. (NASDAQ: PULM) ended the last transaction at $0.83, with a change of -0.06%. The daily volume was calculated
Read MoreTheravance Biopharma, Inc. (NASDAQ: TBPH) spotted trading -17.81% off 52-week high price. On the other end, the stock has been
Read More